Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials
John W. Eikelboom, Jeffrey I. Weitz
Topics & Concepts
ApixabanRivaroxabanWarfarinMedicineVitamin K antagonistInternal medicinePharmacologyAtrial fibrillationAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsVenous Thromboembolism Diagnosis and Management